Miquel Lozano

Apr 8, 2024 | onlinelibrary.wiley.com | Miquel Lozano

Corresponding Author Miquel Lozano Editor-in-Chief Vox Sanguinis Department of Haemotherapy and Haemostasis, Hospital Clínic de Barcelona, Barcelona, Spain University of Barcelona, Barcelona, Spain Correspondence Miquel Lozano, Department of Haemotherapy and Haemostasis, Hospital Clínic de Barcelona, Villarroel 170, 08036 Barcelona, Spain. Email: [email protected] for more papers by this author

May 4, 2023 | frontiersin.org | Yacine Boulaftali |Kirk A Easley |Geoffrey D Wool |Miquel Lozano

Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the infectious agent responsible for Coronavirus Disease 2019 (COVID-19) (1). In some patients, COVID-19 results in acute respiratory distress syndrome and multi-organ failure due in part to the proinflammatory cytokines produced during the immune response, referred as the “cytokine storm”. At cellular level, cytokine-driven leakage of the pulmonary endothelium contributes to COVID-19 pathogeny (2).